Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$9,922 Mln
P/E Ratio
95.45
P/B Ratio
2.38
Industry P/E
--
Debt to Equity
0.13
ROE
0.03 %
ROCE
2.23 %
Div. Yield
0 %
Book Value
29.9
EPS
0.74
CFO
$1,783.21 Mln
EBITDA
$2,403.17 Mln
Net Profit
$1,293.16 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Globus Medical (GMED)
| -11.35 | -12.84 | -11.27 | 41.46 | 1.91 | 12.79 | 11.53 |
|
BSE Sensex
| -1.72 | 1.54 | -1.46 | 6.66 | 9.95 | 20.78 | 10.53 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Globus Medical (GMED)
| 54.65 | -28.25 | 2.87 | 10.70 | 10.77 | 36.04 | 5.27 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 16.45 | 11,350.65 | 16.03 | 12.69 | |
| 69.68 | 8,796.70 | 23.23 | 11.07 | |
| 166.16 | 9,319.12 | -- | -25.23 | |
| 280.14 | 10,500.20 | 778.91 | 1.2 |
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine... products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Address: 2560 General Armistead Avenue, Audubon, PA, United States, 19403 Read more
Co-Founder & Executive Chairman
Mr. David C. Paul
Co-Founder & Executive Chairman
Mr. David C. Paul
Headquarters
Audubon, PA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Globus Medical (GMED) stood at $ 5,252 Mln as on 31-Dec-24
The share price of Globus Medical (GMED) is $73.32 (NYSE) as of 21-Mar-2025 13:44 EDT. Globus Medical (GMED) has given a return of 1.91% in the last 3 years.
Globus Medical (GMED) has a market capitalisation of $ 9,922 Mln as on 19-Mar-2025. As per Value Research classification, it is a Small Cap company.
The P/E ratio of Globus Medical (GMED) is 95.45 times as on 19-Mar-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Globus Medical (GMED) and enter the required number of quantities and click on buy to purchase the shares of Globus Medical (GMED).
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Address: 2560 General Armistead Avenue, Audubon, PA, United States, 19403
The CEO & director of Mr. David C. Paul. is Globus Medical (GMED), and CFO & Sr. VP is Mr. David C. Paul.
There is no promoter pledging in Globus Medical (GMED).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,135
|
|
|
1,050
|
|
|
932
|
|
|
880
|
| Globus Medical (GMED) | Ratios |
|---|---|
|
Return on equity(%)
|
2.52
|
|
Operating margin(%)
|
8.72
|
|
Net Margin(%)
|
4.09
|
|
Dividend yield(%)
|
--
|
Yes, TTM profit after tax of Globus Medical (GMED) was $103 Mln.
$-0.59
(
